Market opportunities lie in the expansion of medical weight loss programs, rising demand for GLP-1 drugs, and increased roles for physicians and bariatricians in weight management. With declining ...

Millions of Americans taking blockbuster weight-loss drugs like Ozempic and Mounjaro are eating less food overall. But what ...

Marconi, who died in 2024 at age 89, made his fortune through the multilevel marketing giant Herbalife, creating the nutrition company with Mark Hughes in the 1980s and supplying the brand’s lines of ...

Dubbed Marconi Ranch, the 1,200-acre San Juan Capistrano property comes with a chapel, observatory, and wildlife sanctuary.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Herbalife (NYSE:HLF ...

For many women in the Asia-Pacific region, including the Philippines, the day often begins before sunrise and ends long after work hours. Balancing ...

Detailed price information for Edgewell Personal Care (EPC-N) from The Globe and Mail including charting and trades.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...